Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
Synthesizing the Law for Synthetic Biology? – An introduction to emerging legal challenges
Minssen, Timo (Lecturer)
26 Nov 2013Activity: Talk or presentation types › Lecture and oral contribution
Synthetic Biology and Open Innovation: Presentation at University of Cambridge
Minssen, Timo (Panel member)
28 Jan 2016Activity: Talk or presentation types › Lecture and oral contribution
THE ACCESS CHALLENGE IN THE 21ST CENTURY: EMERGING ISSUES IN INTELLECTUAL PROPERTY LAWS AND KNOWLEDGE GOVERNANCE : Bucerius Law School-Hamburg, Germany
Minssen, Timo (Participant)
18 May 2012 → 19 May 2012Activity: Participating in an event - types › Organisation of and participation in conference
TRIPS & the Life Sciences”- Webinar 4: Data Exclusivities and TRIPS Art. 39.3
Minssen, Timo (Organizer) & Wested, Jakob (Organizer)
18 Jan 2018Activity: Participating in an event - types › Organisation of and participation in conference
Taking on the challenges to biomedical innovation- A new Center for Advanced Studies in Biomedical Innovation Law (CeBIL) at UCPH - Talk at Yale Club of New York
Minssen, Timo (Invited speaker)
11 Sep 2017Activity: Talk or presentation types › Lecture and oral contribution
Technology-Driven Disruption of Healthcare & "UI Layer" Privacy-by-Design
Corrales Compagnucci, Marcelo (Speaker), Fenwick, M. (Other), Haapio, H. (Other), Minssen, Timo (Other) & Vermeulen, E. P. M. (Other)
27 Feb 2020Activity: Talk or presentation types › Lecture and oral contribution
The 2012 High Technology Protection Summit, Seattle (US)
Minssen, Timo (Participant)
27 Jul 2012 → 28 Jul 2012Activity: Participating in an event - types › Organisation of and participation in conference
The ATRIP 2012 Congress, Chicago (US)
Minssen, Timo (Participant)
29 Jul 2012 → 2 Aug 2012Activity: Participating in an event - types › Organisation of and participation in conference
The Approval of Biosimilars in the US – novel guidelines and developments
Minssen, Timo (Lecturer)
15 Aug 2012Activity: Talk or presentation types › Lecture and oral contribution
The CAFC's decision in the "Myriad" gene patenting case: Background, outcome and ramifications
Minssen, Timo (Speaker)
16 Sep 2011Activity: Talk or presentation types › Lecture and oral contribution
ID: 16150437
Most downloads
-
4329
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2191
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2078
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published